MedPath
NMPA Approval

Levornidazole and Sodium Chloride Injection

国药准字H20247317

December 13, 2024

国药准字H20210040

Drug Information

左奥硝唑氯化钠注射液

注射剂

100ml:左奥硝唑0.5g与氯化钠0.825g

化学药品

December 13, 2024

Company Information

Applicant Company

北京市通州区榆景东路6号院31号楼3层101

Manufacturing Company

石家庄高新技术产业开发区槐安东路518号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左奥硝唑氯化钠注射液 - NMPA 批准文号 | MedPath